T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used

References

1. Andersen M. M., Ronne T. 1991; Side effects with Japanese encephalitis vaccine. Lancet 337:1044
   [Google Scholar]
2. Belosevic M., Finboolm D. S., Meide P. V. D., Slayter M. Z., Nacy C. A. 1989; Administration of monoclonal anti IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major . J Immunol 143:266–271
   [Google Scholar]
3. Chen H. W., Pan C. H., Liau M. Y., Jou R., Tsai C. J., Wu H. J., Lin Y. L., Tao M. H. 1999; Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73:10137–10145
   [Google Scholar]
4. Comoy E. E., Vendeville C., Capron A., Thyphronitis G. 1997; Infection with Salmonella typhimurium modulates the immune response to Schistosoma mansoni Gluthione-S-Transferase. Infect Immun 65:3261–3266
   [Google Scholar]
5. Coutelier J. P., Vanderlogt T. T. M., Heesen F. W. A., Vink A., Snick J. V. 1988; Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168:2373–2378
   [Google Scholar]
6. Desai A., Ravi V., Chandramuki A., Gourie-Devi M. 1994; Detection of neutralizing antibodies to Japanese encephalitis virus in the cerebrospinal fluid using a rapid microneutralization test. Serodiag Immunother Infect Dis 6:130–134
   [Google Scholar]
7. Desai A., Ravi V., Chandramuki A., Gourie-Devi M. 1995; Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus. Microbiol Immunol 39:269–273
   [Google Scholar]
8. Eckels K. H., Yong-Xin Y., Duboid D. R., Marchette N. V., Trent D. W., Johnson A. J. 1988; Japanese encephalitis virus live attenuated vaccine, Chinese strain SA 14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6:513–518
   [Google Scholar]
9. Finkleman F. D., Holmes J., Katona I. M. 7 other authors 1990; Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8:303–333
   [Google Scholar]
10. Gould E. A., Clegg J. C. S. 1991; Growth, titration and purification of alphaviruses and flaviviruses. In Virology, a Practical Approach pp  44–78 Edited by Mahy B. W. J. Oxford, UK: Oxford University Press;
    [Google Scholar]
11. Hanna J. N., Ritchie S. A., Phillips D. A., Shield J., Bailey M. C., Mackenzie J. S., Poidinger M., McCall B. J., Mills P. J. 1996; An outbreak of Japanese encephalitis in Torres strait, Australia, 1995. Med J Aust 165:256–260
    [Google Scholar]
12. Hu-Li J., Huang H., Ryan J., Paul W. E. 1997; In differentiated CD4⁺ T cells, interleukin 4 production is cytokine autonomous, whereas interferon-gamma is cytokine dependent. Proc Natl Acad Sci U S A 94:3189–3194
    [Google Scholar]
13. Igarashi A., Tanaka M., Morita K. 1994; Detection of West Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol 38:827–830
    [Google Scholar]
14. Keane-Myers A., Nickell S. P. 1995; Role of IL-4 and IFN- γ in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155:2020–2028
    [Google Scholar]
15. Ku C. C., King C. C., Lin C. Y., Hsu H. L., Chen L. Y., Yueh Y. Y., Chang G. J. J. 1994; Homologous and heterologous neutralization antibody responses after immunization with Japanese Encephalitis Virus vaccine among Taiwan children. J Med Virol 44:122–131
    [Google Scholar]
16. Li J., Scott P., Farrell J. P. 1996; In vivo alterations in cytokine production following IL-12 and anti IL-4 antibody treatment of CB6F1 mice with chronic cutaneous Leishmaniasis. Infect Immun 64:5248–5254
    [Google Scholar]
17. Lin Y. L., Chen L. K., Liao C. L., Yeh T. H., Ma S. H., Chen J. L., Huang Y. L., Chen S. S., Chiang H. Y. 1998; DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72:191–200
    [Google Scholar]
18. Mason P. W., Pincus S., Fournier M. J., Mason T. L., Shope R. E., Paoletti E. 1991; Japanese encephalitis virus–vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal Japanese encephalitis virus infection. Virology 180:294–305
    [Google Scholar]
19. Mathur A., Arora K. L., Chaturvedi U. C. 1983; Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 64:805–811
    [Google Scholar]
20. Monath T. P., Tsai T. F. 1997 Flaviviruses. In A Textbook of Clinical Virology , pp. 1133–1185 Edited by Richman D. D., Whitley R. J., Hayden F. G. New York: Churchill Livingstone;
    [Google Scholar]
21. Muralikrishna K., Ravi V., Manjunath R. 1996; Protection of adult but not newborn mice against intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus specific T lymphocytes: requirement of L3T4⁺ cells. J Gen Virol 77:705–714
    [Google Scholar]
22. Pan H. C., Chen H. W., Huang H. W., Tao M. H. 2001; Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8⁺ cytotoxic T-cell responses. J Virol 75:11457–11463
    [Google Scholar]
23. Prasad S. R., Kumar V., Marwah R. K. 1993; An epidemic of encephalitis in Haryana: serological evidence for Japanese encephalitis in a few patients. Indian Pediatr 30:905–910
    [Google Scholar]
24. Ramakrishna C., Desai A., Shankar S. K., Chandramuki A., Ravi V. 1999; Oral immunization of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine 17:3102–3108
    [Google Scholar]
25. Rao Bhao K. N., Singh G., Gowal D., Saxena S. N., Kobayashi M., Oya A., Yoshioka I. 1988; Safety and efficacy of Japanese encephalitis vaccine produced in India. Indian J Med Res 88:301–306
    [Google Scholar]
26. Romagnani S. 1994; Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227–251
    [Google Scholar]
27. Scott P. 1991; IFN- γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149–3155
    [Google Scholar]
28. Seder R. A., Paul W. E. 1994; Acquisition of lymphokine-producing phenotype by CD4⁺ T cells. Annu Rev Immunol 12:635–673
    [Google Scholar]
29. Seder R. A., Mosmann T. M. 1998; Differentiation of effector phenotypes of CD4⁺ and CD8⁺ T cells. In Fundamental Immunology pp  879–908 Edited by Paul W. E. New York: Lippincott–Raven;
    [Google Scholar]
30. Skvaril F., Schilt U. 1984; Characterization of the subclass and light chain types of IgG antibodies to rubella. Clin Exp Immunol 55:671–676
    [Google Scholar]
31. Snapper C. M., Paul W. E. 1987; IFN- γ and B-cell stimulating factor 1 reciprocally regulate immunoglobulin isotype production. Science 236:944–947
    [Google Scholar]
32. Stevens T. L., Bossie A., Sanders V. M., Fernandez-Bortran R., Coffman R. L., Mosmann T. R., Vitetta E. S. 1988; Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:225
    [Google Scholar]
33. Thakare J. P., Gore M. M., Risbud K. R., Banerjee K., Ghosh S. N. 1991; Detection of virus specific IgG subclasses in Japanese encephalitis patients. Indian J Med Res 93:271–276
    [Google Scholar]
34. World Health Organization (WHO) 1998; Japanese encephalitis vaccine – WHO position paper. Wkly Epidemiol Rec 73:337–344
    [Google Scholar]